Therapeutic agent for cancer which comprises combination of il-18 and molecule-targeting antibody

• 收藏
• 分享

专利权人:

HYOGO COLLEGE OF MEDICINE

发明人:

Okamura, Haruki,Yamanishi, Kyosuke,Li, Wen

申请号：

NZ72939515

公开号：

NZ729395A

申请日:

2015.08.07

申请国别(地区):

NZ

年份:

2018

代理人:

摘要：

A cancer therapeutic agent according to an embodiment of the present invention contains, as active ingredients, IL-18 and one or more antibodies selected from the group consisting of an anti-PD-L1 antibody, an anti-PD-1 antibody, an anti-PD-L2 antibody, an anti-CTLA-4 antibody, an anti-CD25 antibody, an anti-CD33 antibody, and an anti-CD52 antibody.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/